BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Biofrontera Inc. to Report Third Quarter 2025 Financial Results on November 12, 2025 and Host a Conference Call on November 13, 2025

  November 6, 2025

   · 

  1 min read
• Press Releases

  Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - November 6, 2025

  November 6, 2025

   · 

  1 min read
• Press Releases

  Progyny, Inc. Announces Third Quarter 2025 Results

  November 6, 2025

   · 

  29 min read
• Press Releases

  Denali Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights

  November 6, 2025

   · 

  13 min read
• Press Releases

  Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress

  November 6, 2025

   · 

  11 min read
• Press Releases

  OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update

  November 6, 2025

   · 

  11 min read
• Press Releases

  Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer

  November 6, 2025

   · 

  8 min read
• Press Releases

  ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

  November 6, 2025

   · 

  24 min read
• Press Releases

  Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

  November 6, 2025

   · 

  24 min read
• Press Releases

  Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

  November 6, 2025

   · 

  15 min read